Dr. Glenn van Langenhove - REDUCE Studie

Related Links

  • Dr. Glenn van Langenhove über die REDUCE Studie Wie nutzen Patienten CardioSecur ACTIVE? Dies wurde in REDUCE, der ersten explorativen Studie getestet.In diesem Video berichtet Kardiologe Dr. Glenn van Langenhove REDUCE und darüber, wie Patienten unser mobiles EKG verwenden.

Zurück

Neueste Artikel

[Translate to German:]

Meet us at ESC Congress 2025 in Madrid!

We’re excited to present the first Vector-ECGi solution designed for advanced pacing techniques like LBBAP, as well as broader EP applications. Exhibiting at the ESC Congress from 29 August to 1…

Company
Company

Meet us at the 78th Annual Scientific Meeting

We’re thrilled to be part of the 78th Annual Scientific Meeting of the International Airline Medical Association (IAMA).

Join us at our booth and discover CardioSecur Aviation: the ultralight &…

Company
Company

Meet us at the Heart Rhythm 2025 in San Diego

The Heart Rhythm Society Annual Meeting is about to begin—and we’re excited to be part of it!

Come visit CardioSecur at booth 2808 to explore how our mobile 12+lead ECG system and our latest…

Company
Company

Meet us at the EHRA 2025 in Vienna

We’re excited to exhibit at the European Heart Rhythm Association (EHRA) Congress from March 30 – April 1, 2025, in Vienna. Visit us at Booth B300 to discover our cutting-edge ECG solutions designed…

Company
Company